Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pharmaceutical combinations comprising insulin and at least an agent selected from meloxicam, bromfenac sodium, acetylsalicylic acid, salicyclic acid and paracetamol

Pharmaceutical combinations comprising insulin and at least an agent selected from meloxicam, bromfenac sodium, acetylsalicylic acid, salicyclic acid and paracetamol

US Patent 11510967 · Granted Nov 29, 2022

Estimated economic value: $1,189,298,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Closed loop control of physiological glucose2025
Fusion proteins2024
Closed loop control of physiological glucose2024
Pharmaceutical compositions containing anti-beta amyloid antibodies2023
Fusion proteins and methods of use2022
Infusion set with components comprising a polymeric sorbent to reduce the concen2021
Silicone based membranes for use in implantable glucose sensors2021
Fusion proteins2020
Silicone based membranes for use in implantable glucose sensors2018
Blood glucose lowering compound2018
Fusion proteins2018
Septum seal2017